NO963052L - Process for solubilizing poorly soluble pharmaceutically active components - Google Patents

Process for solubilizing poorly soluble pharmaceutically active components

Info

Publication number
NO963052L
NO963052L NO963052A NO963052A NO963052L NO 963052 L NO963052 L NO 963052L NO 963052 A NO963052 A NO 963052A NO 963052 A NO963052 A NO 963052A NO 963052 L NO963052 L NO 963052L
Authority
NO
Norway
Prior art keywords
pharmaceutically active
active components
poorly soluble
soluble pharmaceutically
solubilizing poorly
Prior art date
Application number
NO963052A
Other languages
Norwegian (no)
Other versions
NO963052D0 (en
Inventor
Dadi Jamshed Dhabhar
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO963052D0 publication Critical patent/NO963052D0/en
Publication of NO963052L publication Critical patent/NO963052L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Fremgangsmåte for å forbedre oppløseligheten av vanskelig oppløselige farmasøytisk aktive komponenter i en blanding av polyetylenglykol og propylenglykol ved anvendelse av et poly- vinylpyrrolidon med en spesifikk viskositetsmidlere molekyl- vekt på fra omtrent 5.000 til omtrent 25.000.A process for improving the solubility of poorly soluble pharmaceutically active components in a mixture of polyethylene glycol and propylene glycol using a polyvinylpyrrolidone having a specific viscosity average molecular weight of from about 5,000 to about 25,000.

NO963052A 1994-01-24 1996-07-22 Process for solubilizing poorly soluble pharmaceutically active components NO963052L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18557694A 1994-01-24 1994-01-24
PCT/US1995/001018 WO1995019759A1 (en) 1994-01-24 1995-01-24 Process for solubilizing difficultly soluble pharmaceutical actives

Publications (2)

Publication Number Publication Date
NO963052D0 NO963052D0 (en) 1996-07-22
NO963052L true NO963052L (en) 1996-09-24

Family

ID=22681571

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963052A NO963052L (en) 1994-01-24 1996-07-22 Process for solubilizing poorly soluble pharmaceutically active components

Country Status (14)

Country Link
EP (1) EP0741560A1 (en)
JP (1) JPH09508128A (en)
CN (1) CN1138827A (en)
AU (1) AU706890B2 (en)
BR (1) BR9506564A (en)
CA (1) CA2181241C (en)
CZ (1) CZ210496A3 (en)
FI (1) FI962948A0 (en)
MX (1) MX9602955A (en)
NO (1) NO963052L (en)
NZ (1) NZ279443A (en)
PL (1) PL315635A1 (en)
SK (1) SK96196A3 (en)
WO (1) WO1995019759A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998058637A1 (en) * 1996-06-20 1998-12-30 Mcneil-Ppc Acetaminophen and diphenhydramine analgesics
ZA975444B (en) * 1996-06-20 1998-12-21 Mcneil Ppc Inc Acetaminophen and meclizine hydrochloride analgesics
FR2751875B1 (en) * 1996-08-05 1998-12-24 Scr Newpharm NOVEL STABLE LIQUID FORMULATIONS BASED ON PARACETAMOL AND THEIR METHOD OF PREPARATION
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
DE69940769D1 (en) * 1998-01-20 2009-06-04 Applied Analytical Ind Inc ORAL LIQUID COMPOSITIONS
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
US20020086878A1 (en) * 1999-01-11 2002-07-04 Douglas Joseph Dobrozsi Compositions having improved stability
US20020082307A1 (en) * 1999-01-11 2002-06-27 Dobrozsi Douglas Joseph Compositions having improved stability
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
FR2796843B1 (en) * 1999-07-29 2003-05-09 So Ge Val Sa CONCENTRATED AND STABILIZED ANTIPYRETIC COMPOSITION FOR VETERINARY USE INTENDED TO BE INCORPORATED IN ANIMAL FEEDING AS WELL AS A METHOD OF INCORPORATING THIS COMPOSITION INTO ANIMAL BEVERAGE WATER
US6251426B1 (en) * 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
DE10011032A1 (en) * 2000-03-07 2001-09-13 Bayer Ag Stable solutions of acetylsalicylic acid in mixture of organic solvent and water, useful for topical treatment of pain, especially pain associated with herpes zoster
KR20020069387A (en) * 2001-02-26 2002-09-04 진양제약주식회사 Mixing method of composition containing doxylamine succinate and soft capsule preparation containing the composition
JP2004538309A (en) * 2001-07-31 2004-12-24 ワイエス Sucralose formulation to mask unpleasant taste
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
CN100379406C (en) * 2003-09-22 2008-04-09 北京德众万全药物技术开发有限公司 Method for preparing tiny pellets of difficult soluble drugs and formulation containing the pellets
CA2627292C (en) * 2005-10-26 2012-04-17 Banner Pharmacaps, Inc. Hydrophilic vehicle-based dual controlled release matrix system
DE102005053066A1 (en) 2005-11-04 2007-05-10 Basf Ag Use of copolymers as solubilizers for sparingly water-soluble compounds
EP1962908A2 (en) * 2005-12-09 2008-09-03 Basf Se Use of polyvinyl lactam-polyoxyalkylene block copolymers as solubilisers for poorly water-soluble compounds
US8637076B2 (en) 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
JP2008184430A (en) * 2007-01-30 2008-08-14 Ss Pharmaceut Co Ltd Soft capsule
CA2690488C (en) * 2010-01-19 2013-06-11 Accucaps Industries Limited Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
CA2690490C (en) * 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
EP3158991B1 (en) 2010-01-28 2021-03-17 Eagle Pharmaceuticals, Inc. Formulations of bendamustine
WO2013142359A1 (en) 2012-03-20 2013-09-26 Eagle Pharmaceuticals, Inc. Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration
DK2827862T3 (en) 2012-03-20 2024-02-12 Eagle Pharmaceuticals Inc FORMULATIONS OF BENDAMUSTINE
KR101695580B1 (en) * 2013-02-28 2017-01-13 화이자 인코포레이티드 Enhanced stability of novel liquid compositions
GB201506755D0 (en) * 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
TWI586379B (en) 2015-06-29 2017-06-11 永信藥品工業股份有限公司 Method of preparing very slightly soluble drug with solid dosage form
WO2017062997A1 (en) 2015-10-09 2017-04-13 Reckitt Benckiser Llc Pharmaceutical formulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives

Also Published As

Publication number Publication date
SK96196A3 (en) 1997-03-05
EP0741560A1 (en) 1996-11-13
WO1995019759A1 (en) 1995-07-27
NZ279443A (en) 1998-04-27
BR9506564A (en) 1997-09-02
FI962948A (en) 1996-07-23
CA2181241A1 (en) 1995-07-27
MX9602955A (en) 1997-06-28
CZ210496A3 (en) 1996-12-11
FI962948A0 (en) 1996-07-23
CN1138827A (en) 1996-12-25
PL315635A1 (en) 1996-11-25
AU706890B2 (en) 1999-07-01
JPH09508128A (en) 1997-08-19
NO963052D0 (en) 1996-07-22
AU1607595A (en) 1995-08-08
CA2181241C (en) 2000-04-25

Similar Documents

Publication Publication Date Title
NO963052L (en) Process for solubilizing poorly soluble pharmaceutically active components
PL300194A1 (en) Interferon conjugate, method of obtaining same and pharmaceutical composition containing it
NO971889L (en) Compounds and compositions for delivery of active agents
DK0620828T4 (en) Cyclodextrin derivatives with increased water solubility and use thereof
DZ2420A1 (en) Novel formulations comprising amoxycillin and clavulanate and process for their preparation.
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
NO944764D0 (en) Inclusion Complexes in Aqueous Solutions of Benzothiophene Compounds with Water-Soluble Cyclodextrins and Pharmaceutical Formulations and Methods
WO1996015786A3 (en) Oral compositions containing ondansetron
TR199801861T2 (en) Pharmaceutically useful compositions.
FR2545354B1 (en) PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION BASED ON NIMODIPIN AND METHOD FOR THE PREPARATION THEREOF
AU661591B2 (en) 5,10-methylenetetrahydrofolic acid-cyclodextrin inclusion compounds
FI910895A (en) Process for the preparation of therapeutically useful 4- (di-n-propyl) amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenzo [c, d] indole hippurate
AU4434189A (en) An anti-human immunodeficiency virus composition
CA2089853A1 (en) Polyethylene glycol-hirudine conjugates, process for their preparation, and their use in thrombosis therapy
IL129616A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
FR2701478B1 (en) Vitamin E derivatives containing quaternary nitrogen and methods for their preparation.
IL129625A0 (en) Novel (-)-enantionmers of CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IL129627A0 (en) Novel CIS-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
IE890275L (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
ES2150400A6 (en) Pharmaceutical composition for treatment of ulcer type disorders of gastro-intestinal tract, comprises methyl polysiloxanol and solvent or carrier pharmaceutically acceptable for oral use
HUT70840A (en) 2,2-dialkyl-2h-1-benzopiran and 2,2-dialkil-3,4-dihydro-3-hydroxy-2h-1-benzo-pyran derivatives, process for preparing them and pharmaceutical compositions comprising them as an active agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application